BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

442 related articles for article (PubMed ID: 34433712)

  • 1. Cranial Nerve Involvement and Dysautonomia in Post-COVID-19 Guillain-Barré Syndrome.
    Kakumoto T; Kobayashi S; Yuuki H; Kainaga M; Shirota Y; Hamada M; Hashimoto Maeda M; Kubota A; Kawai M; Saito M; Ishiura H; Toda T
    Intern Med; 2021 Nov; 60(21):3477-3480. PubMed ID: 34433712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation.
    Biassoni E; Assini A; Gandoglia I; Benedetti L; Boni S; Pontali E; Feasi M; Gandolfo F; Del Sette M
    J Neurovirol; 2021 Aug; 27(4):662-665. PubMed ID: 34341959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 50-Year-Old Patient with Guillain-Barré Syndrome after COVID-19: A Case Report.
    Chmiela T; Rzepka M; Krzystanek E; Gorzkowska A
    Medicina (Kaunas); 2021 Jul; 57(8):. PubMed ID: 34440980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guillain-Barré syndrome with associated unilateral ptosis without ophthalmoplegia - a rare presentation: a case report and review of the literature.
    Ralapanawa U; Kumarihamy P; Jayalath T; Udupihille J
    J Med Case Rep; 2019 Jul; 13(1):221. PubMed ID: 31324211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
    Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
    J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Case of Guillain-Barré Syndrome Associated With COVID-19.
    Rajdev K; Victor N; Buckholtz ES; Hariharan P; Saeed MA; Hershberger DM; Bista S
    J Investig Med High Impact Case Rep; 2020; 8():2324709620961198. PubMed ID: 32981333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.
    Chakraborty T; Kramer CL; Wijdicks EFM; Rabinstein AA
    Neurocrit Care; 2020 Feb; 32(1):113-120. PubMed ID: 31297663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A 44-Year-Old Hispanic Man with Loss of Taste and Bilateral Facial Weakness Diagnosed with Guillain-Barré Syndrome and Bell's Palsy Associated with SARS-CoV-2 Infection Treated with Intravenous Immunoglobulin.
    Khaja M; Gomez GPR; Santana Y; Hernandez N; Haider A; Lara JLP; Elkin R
    Am J Case Rep; 2020 Oct; 21():e927956. PubMed ID: 33128540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Miller-Fisher Syndrome and Guillain-Barre Syndrome overlap syndrome in a patient post Oxford-AstraZeneca SARS-CoV-2 vaccination.
    Dang YL; Bryson A
    BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34848426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2-associated Guillain-Barré syndrome with dysautonomia.
    Su XW; Palka SV; Rao RR; Chen FS; Brackney CR; Cambi F
    Muscle Nerve; 2020 Aug; 62(2):E48-E49. PubMed ID: 32445201
    [No Abstract]   [Full Text] [Related]  

  • 11. The challenge of diagnosing Guillain-Barre syndrome in patients with COVID-19 in the intensive care unit.
    Diaz P; Leveque M; Hautecloque G; Sellal F; Augereau O; Lita L; Biegle E; Belilita L; Bouterra C; Rerat P; Alvarez-Gonzalez A; Martinot M; Gerber V
    J Neuroimmunol; 2022 May; 366():577842. PubMed ID: 35339941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guillain-Barré syndrome in SARS-CoV-2 infection: an instant systematic review of the first six months of pandemic.
    Uncini A; Vallat JM; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2020 Oct; 91(10):1105-1110. PubMed ID: 32855289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré Syndrome Presenting as Facial Diplegia after COVID-19 Vaccination: A Case Report.
    Rossetti A; Gheihman G; O'Hare M; Kosowsky JM
    J Emerg Med; 2021 Dec; 61(6):e141-e145. PubMed ID: 34538679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Isolated facial diplegia as an atypical variant of Guillain-Barre syndrome after suspected SARS-CoV-2 infection].
    Lavilla Olleros C; López-Rubio M; Fanciulli C; González-Munera A; Millán Núñez-Cortés J
    Rev Fac Cien Med Univ Nac Cordoba; 2021 Dec; 78(4):405-407. PubMed ID: 34962738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guillain-Barré Syndrome with Facial Diplegia Related to SARS-CoV-2 Infection.
    Chan JL; Ebadi H; Sarna JR
    Can J Neurol Sci; 2020 Nov; 47(6):852-854. PubMed ID: 32468972
    [No Abstract]   [Full Text] [Related]  

  • 16. Bilateral Facial Palsy and Hyperreflexia as the Main Clinical Presentation in Guillain-Barré Syndrome.
    Albuainain G
    Am J Case Rep; 2021 Oct; 22():e932757. PubMed ID: 34597290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SARS-CoV-2-associated Guillain-Barré syndrome is a para-infectious disease.
    Li X; Wang Y; Wang H; Wang Y
    QJM; 2021 Nov; 114(9):625-635. PubMed ID: 34043803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guillain-Barré syndrome associated with leptomeningeal enhancement following SARS-CoV-2 infection.
    Sancho-Saldaña A; Lambea-Gil Á; Liesa JLC; Caballo MRB; Garay MH; Celada DR; Serrano-Ponz M
    Clin Med (Lond); 2020 Jul; 20(4):e93-e94. PubMed ID: 32518103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Finger Drop-Dominant Variant of Guillain-Barre Syndrome in a Patient With COVID-19: A Case Report.
    Kang M; Seok HY
    J Korean Med Sci; 2022 May; 37(20):e160. PubMed ID: 35607739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a causal nexus between COVID-19 infection, COVID-19 vaccination, and Guillain-Barré syndrome?
    Zheng X; Fang Y; Song Y; Liu S; Liu K; Zhu J; Wu X
    Eur J Med Res; 2023 Feb; 28(1):98. PubMed ID: 36841799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.